UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
11
Insider Sells Sum
$281,908.79

Insider Activity of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO

According to the SEC Form 4 filings, UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO, being in a position of

  1. 10 percent owner at Aileron Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 74744 shares for $281,909,
    over all time since 2024-04-29, has bought 0 shares, and sold 74744 shares for $281,909.

The largest sale of all time was on 2024-05-01 and amounted to 20315 shares of Aileron Therapeutics, Inc. for $85,473.

Biography of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO

No biography is available at this moment.

2024-06-17SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
4,707
0.0219%
$3.25$15,298-14.49%
2024-06-14SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
1,900
0.009%
$3.30$6,270-14.6%
2024-06-12SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
9,342
0.0435%
$3.25$30,362-14.77%
2024-06-11SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
5,752
0.0269%
$3.26$18,744-13.93%
2024-06-10SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
9,577
0.046%
$3.30$31,604-12.26%
2024-06-07SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
1,740
0.0081%
$3.26$5,664-13.89%
2024-06-06SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
4,284
0.0199%
$3.29$14,104-15.2%
2024-06-05SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
6,291
0.0291%
$3.30$20,760-15.3%
2024-05-01SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
20,315
0.1211%
$4.21$85,473-25.36%
2024-04-30SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
90
0.0006%
$4.97$448-31.43%
2024-04-29SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
10,746
0.0637%
$4.95$53,182-36.48%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.